US 7875712
Caspase inhibitors and uses thereof
granted A61KA61K31/4015A61K31/403
Quick answer
US patent 7875712 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4015, A61K31/403, A61K31/407, A61K31/435